Dual Integrin αvβ3 and GRPR Targeting PET Imaging in Breast Cancer Patients
NCT02749019
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
68Ga-NOTA-BBN-RGD
Sponsor
Peking Union Medical College Hospital
Collaborators
[object Object]